Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial

被引:212
作者
Ishani, Areef
Grandits, Greg A.
Grimm, Richard H.
Svendsen, Kenneth H.
Collins, Allan J.
Prineas, Ronald J.
Neaton, James D.
机构
[1] Univ Minnesota, Sch Publ Hlth, Nephrol Sect, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Publ Hlth, Ctr Epidemiol & Clin Res, Dept Med,Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Publ Hlth, Div Renal Dis & Hypertens, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA
[5] US Renal Data Syst, Minneapolis, MN USA
[6] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 05期
关键词
D O I
10.1681/ASN.2005091012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The incidence of ESRD is increasing rapidly. Limited information exists regarding early markers for the development of ESRD. This study aimed to determine over 25 yr the risk for ESRD associated with proteinuria, estimated GFR (eGFR), and hematocrit in men who did not have identified kidney disease and were randomly assigned into the Multiple Risk Factor Intervention Study (MRFIT). A total of 12,866 men who were at high risk for heart disease were enrolled (1973 to 1975) and followed through 1999. Renal replacement therapy was ascertained by matching identifiers with the United States Renal Data System's data; vital status was from the National Death Index. Men who initiated renal replacement therapy or died as a result of kidney disease were deemed to have developed ESRD. Dipstick urine for proteinuria, eGFR, and hematocrit were related to development of ESRD. During 25 yr, 213 (1.7%) men developed ESRD. Predictors of ESRD were dipstick proteinuria of 1+ or >= 2+ (hazard ratio [HR] 3.1 [95% confidence interval (CI) 1.8 to 5.4] and 15.7 [95% CI 10.3 to 23.9] respectively) and an eGFR of < 60 ml/min per 1.73 m(2) (HR 2.4; 95% CI 1.5 to 3.8). Correlation between eGFR and serum creatinine was 0.9; the risk for ESRD with a 1-SD difference of each was identical (HR 1.21). Bivariate analysis demonstrated a 41-fold increase in ESRD risk in those with an eGFR < 60 ml/min per 1.73 m(2) and >= 2+ proteinuria (95% CI 15.2 to 71.1). There was no association between hematocrit and ESRD. Other baseline measures that independently predicted ESRD included age, cigarette smoking, BP, low HDL cholesterol, and fasting glucose. Among middle-aged men who were at high risk for cardiovascular disease but had no clinical evidence of cardiovascular disease or significant kidney disease, dipstick proteinuria and an eGFR value < 60 ml/min per 1.73 m(2) were strong predictors of long-term development of ESRD. It remains unknown whether intervention for proteinuria or early identification of those with chronic kidney disease reduces the risk for ESRD.
引用
收藏
页码:1444 / 1452
页数:9
相关论文
共 35 条
[1]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[2]  
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[3]   Risk of end-stage renal disease in diabetes mellitus - A prospective cohort study of men screened for MRFIT [J].
Brancati, FL ;
Whelton, PK ;
Randall, BL ;
Neaton, JD ;
Stamler, J ;
Klag, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2069-2074
[4]   The role of proteinuria in the progression of chronic renal failure [J].
Burton, C ;
Harris, KPG .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (06) :765-775
[5]   Surrogate markers for cardiovascular disease functional markers [J].
Cohn, JN ;
Quyyumi, AA ;
Hollenberg, NK ;
Jamerson, KA .
CIRCULATION, 2004, 109 (25) :31-46
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, MF ;
Mitch, WE ;
Brenner, BM .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320
[8]  
DISCHINGER P, 1986, CONTROL CLIN TRIALS, V7, pS137
[9]  
Eberly Lynn E, 2004, Clin Trials, V1, P148, DOI 10.1191/1740774504cn018oa
[10]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266